Keyphrases
Rheumatoid Arthritis
100%
Combination Therapy
100%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
100%
Pain Management
100%
Ankylosing Spondylitis
100%
Inflammatory Arthritis
100%
Spondyloarthritis
100%
Psoriatic Arthritis
100%
Monotherapy
90%
Opioids
50%
No Significant Difference
30%
Risk of Bias
30%
Analgesic
30%
Disease-modifying Antirheumatic Drugs (DMARDs)
30%
Neuromodulators
30%
High Risk
20%
Persistent Pain
20%
Pain Treatment
20%
Phenylbutazone
20%
Disease Suppression
20%
High Dose
10%
Randomized Clinical Trial
10%
Subgroup Analysis
10%
Meta-analysis
10%
Selection Criteria
10%
Absence of Evidence
10%
Controlled Experiment
10%
Inclusion Criteria
10%
MEDLINE
10%
Embase
10%
Antidepressants
10%
Pain Scale
10%
Paracetamol
10%
Drug Therapy
10%
Cochrane Library
10%
Search Strategy
10%
Osteoarthritis
10%
Anticonvulsant
10%
Cochrane Central Register of Controlled Trials
10%
Mixed Population
10%
European League against Rheumatism (EULAR)
10%
Adalimumab
10%
Methotrexate
10%
Etanercept
10%
Infliximab
10%
Review Authors
10%
Conflicting Results
10%
Conference Proceedings
10%
American College of Rheumatology
10%
Aspirin
10%
Opioid Analgesics
10%
Hydroxychloroquine
10%
Optimal Therapy
10%
Biologic Therapy
10%
Additional Therapy
10%
Muscle Relaxant
10%
Leflunomide
10%
Inadequate Analgesia
10%
Sulfasalazine
10%
Background Therapy
10%
Psoriatic Spondyloarthritis
10%
Extracted Data
10%
Pharmacology, Toxicology and Pharmaceutical Science
Rheumatoid Arthritis
100%
Combination Therapy
100%
Psoriatic Arthritis
100%
Ankylosing Spondylitis
100%
Spondylarthritis
100%
Inflammatory Arthritis
100%
Monotherapy
75%
Non-Steroidal Anti-Inflammatory Drug
75%
Opiate
41%
Analgesic Agent
25%
Disease
16%
Disease Modifying Antirheumatic Drug
16%
Phenylbutazone
16%
Randomized Controlled Trial
8%
Paracetamol
8%
Osteoarthritis
8%
Acetylsalicylic Acid
8%
Population Study
8%
Antidepressant
8%
Infliximab
8%
Adalimumab
8%
Anticonvulsive Agent
8%
Pharmacotherapy
8%
Randomized Clinical Trial
8%
Controlled Clinical Trial
8%
Rheumatic Disease
8%
Sulfasalazine
8%
Methotrexate
8%
Etanercept
8%
Leflunomide
8%
Muscle Relaxant Agent
8%
Narcotic Analgesic Agent
8%
Hydroxychloroquine
8%
INIS
therapy
100%
inflammation
100%
arthritis
100%
management
100%
pain
100%
ankylosing spondylitis
100%
drugs
76%
patients
29%
diseases
23%
people
23%
analgesics
23%
data
17%
values
17%
control
17%
risks
17%
doses
11%
comparative evaluations
11%
safety
11%
suppression
11%
interventions
11%
populations
11%
inclusions
11%
information
5%
clinical trials
5%
reviews
5%
muscles
5%
libraries
5%
conferences
5%
adults
5%
antidepressants
5%
colleges
5%
proceedings
5%
anticonvulsants
5%
methotrexate
5%
aspirin
5%